Congress, JD(S) pretend to fight each other but are in tacit alliance: PM Modi

Udupi, Jan 16: Admar Mutt Junior seer Eshapriya Theertha Swami is all set to take over the reins of Krishna Mutt during the 250th Paryayotsava, scheduled to be held on January 17 and 18.

The uniqueness lies in the fact that the Admar Mutt, one of the Ashta Mutts of Krishna Mutt in this Temple town Udupi, ushers in the new Paryaya cycle (32nd). The Paryaya of outgoing seer Vidyadheesha Theertha Swami of Palimaru Mutt, Admar’s dwandwa (associate) mutt, marks the end of the cycle of eight mutts.

Under the system initiated by the Madhwa philosopher and saint Madwacharya, the seers of Ashta mutts would take turns to worship Lord Krishna every two months. Seer Vadiraja (1481-1601) ended the system and introduced the system of f running the temple administration once in two years.

Kolhapur, May 27: Praising the Muslims of Ichalkaranji town in the Kolhapur district for making invaluable contribution for setting up of a new intensive care unit in Indira Gandhi Memorial (IGM) hospital for treatment of corona infected patients, Maharashtra Chief Minister Uddhav Thackeray has said that with this donation, they have set an ideal example before the country.

While dedicating a 10-bed ICU unit at IGM hospital online from Mumbai, during Eid al Fitr, Mr Thackeray said that by donating Rs 36 lakh for ICU unit at IGM hospital, the Muslim community has set an ideal example before the country as to how to celebrate the festival.

The Muslims of Ichalkaranji made the donation following an appeal by the state government about avoiding unnecessary expenses for celebrating the Eid.

Minister of State for Health Rajendra Patil-Yadravkar, MP Dharysheel Mane, MLAs Prakash Awade and Raju Awale, district collector Daulat Desai, district superintendent of police Dr Abhinav Deshmukh, Zilla Parishad chief executive officer Aman Mittal, district surgeon Dr B C Kempipatil and others were present on the occasion.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.